-
1 Comment
Sastasundar Ventures Limited is currently in a long term uptrend where the price is trading 138.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 0.7.
Sastasundar Ventures Limited's total revenue rose by 32.6% to $1B since the same quarter in the previous year.
Its net income has increased by 76.7% to $-20M since the same quarter in the previous year.
Finally, its free cash flow grew by 93.6% to $-46M since the same quarter in the previous year.
Based on the above factors, Sastasundar Ventures Limited gets an overall score of 5/5.
| CurrencyCode | INR |
|---|---|
| ISIN | INE019J01013 |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Exchange | NSE |
| Market Cap | 8B |
|---|---|
| PE Ratio | None |
| Target Price | 457 |
| Beta | 0.72 |
| Dividend Yield | None |
Sastasundar Ventures Limited operates a digital network of healthcare and portfolio management services in India. The company operates through Financial Services and Healthcare Network segments. It is involved in financing of loans; investment in shares and securities; provision of financial consultancy, professional fees, wealth management, financial planning, distribution, and related services. The company engages in activities for pathology and marketing of healthcare and OTC products through e-commerce portal; and provision of diagnostic services, including pathological/radiological investigation. In addition, the company engages in the supply chain of medicine and wellness products; operates RetailerShakti.com and RetailerShakti mobile app for medicine, wellness, and FMCG products; and supplies products to retail pharmacies and local stores. The company was formerly known as Microsec Financial Services Limited and changed its name to Sastasundar Ventures Limited in November 2016. Sastasundar Ventures Limited was incorporated in 1989 and is based in Kolkata, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SASTASUNDR.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
